[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356122-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dermatology-related-quality-of-life-measured-with-the-dermatology-life-quality-index-in-basal-cell-carcinoma-and-other-non-melanoma-skin-cancers-a-systematic-review-and-exploratory-meta-analysis","Dermatology-Related Quality of Life Measured with the Dermatology Life Quality Index in Basal Cell Carcinoma and Other Non-Melanoma Skin Cancers - A Systematic Review and Exploratory Meta-Analysis","","Background/Objectives: Basal cell carcinoma (BCC) is the most common skin cancer and may negatively influence a patient’s well-being despite low mortality. This systematic review and exploratory meta-analysis evaluated dermatology-related quality of life using exclusively the Dermatology Life Quality Index (DLQI) in BCC and other non-melanoma skin cancers (NMSC). Methods: PubMed, Scopus, and Web of Science searches were performed until 5 April 2026 following PRISMA, with pooled baseline DLQI and pre-to post changes calculated using random effects. Results: Six studies were included; baseline impairment was mild but clinically small, and heterogeneity was very high (I2 > 95%). Treatment improved DLQI modestly, often not exceeding minimal clinically important difference, with limited evidence comparing modalities. Conclusions: Patients experience measurable DLQI impairment before treatment, and DLQI improves after treatment, but the magnitude is modest and further prospective DLQI studies are needed.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dermatology-related-quality-of-life-measured-with-the-dermatology-life-quality-index-in-basal-cell-carcinoma-and-other-non-melanoma-skin-cancers-a-systematic-review-and-exploratory-meta-analysis/356122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dermatology-related-quality-of-life-measured-with-the-dermatology-life-quality-index-in-basal-cell-carcinoma-and-other-non-melanoma-skin-cancers-a-systematic-review-and-exploratory-meta-analysis/356122.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What instrument was used to measure dermatology-related quality of life in this review?","Question",{"text":63,"@type":64},"The study used the Dermatology Life Quality Index (DLQI) exclusively to assess dermatology-related quality of life.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were included studies identified and selected?",{"text":68,"@type":64},"A systematic search of PubMed, Scopus, and Web of Science was conducted until 5 April 2026, following PRISMA guidelines, and studies reporting DLQI outcomes in adult BCC or NMSC populations were included.",{"name":70,"@type":61,"acceptedAnswer":71},"Did treatment improve DLQI scores, and was the change clinically meaningful?",{"text":72,"@type":64},"Treatment was associated with reduced DLQI scores, but the pooled reduction generally fell below the minimal clinically important difference of about four points, indicating modest and not consistently clinically meaningful improvement.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356122,1790811488,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Systematic Review  \nDermatology-Related Quality of Life Measured with the Dermatology Life Quality Index in Basal Cell Carcinoma and Other Non-Melanoma Skin Cancers: A Systematic Review and Exploratory Meta-Analysis  \nJakub Nicer 1, Justyna Tomaszewska 2, Dariusz Jurkiewicz 1, Piotr Rot 1 and Maria Sobol 3, *  \nAcademic Editors: Gianluca Nazzaro and Paulo Filipe  \nReceived: 30 June 2026  \nRevised: 3 August 2026  \nAccepted: 12 August 2026  \nPublished: 17 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Otolaryngology and Oncological Otolaryngology with Clinical Department of Cranio-Maxillofacial Surgery, Military Institute of Medicine—National Research Institute,  \n04-141 Warsaw, Poland; [nicer35@gmail.com](nicer35@gmail.com) (J.N.); [djurkiewicz@wim.mil.pl](djurkiewicz@wim.mil.pl) (D.J.); [rot@autograf.pl](rot@autograf.pl) (P.R.)  \n2 Institute of Mathematics and Cryptology, Military University of Technology, 2 Kaliskiego Str., 00-908 Warsaw, Poland; [justyna.tomaszewska@wat.edu.pl](justyna.tomaszewska@wat.edu.pl)  \n3 Department of Biophysics, Physiology and Pathophysiology, Medical University of Warsaw, 5 Chałubi ´nskiego Str., 02-004 Warsaw, Poland  \n* [Correspondence: maria.sobol@wum.edu.pl](Correspondence: maria.sobol@wum.edu.pl)  \nAbstract  \nBackground/Objectives: Basal cell carcinoma (BCC) is the most common skin cancer and may negatively influence a patient’s well-being despite low mortality. This systematic review and exploratory meta-analysis evaluated dermatology-related quality of life, as measured exclusively by the Dermatology Life Quality Index (DLQI), in patients with BCC and other non-melanoma skin cancers (NMSC). Instruments other than the DLQI, including disease-specific measures of appearance, scarring, fear of recurrence and treatment satisfaction, were outside the scope of the quantitative synthesis. Methods: A systematic search of the PubMed, Scopus, and the Web of Science was conducted until 5 April 2026 following the PRISMA guidelines. Studies reporting DLQI outcomes in adult patients with BCC, squamous cell carcinoma (SCC), or NMSC were included. Pooled baseline DLQI scoresand pre-to post-treatment changes were calculated using a random effects model. Results: Six studies were included. The pooled baseline DLQI score was 3.76 (95% CI: 2.18–5.33) in the BCC-only analysis and 4.07 (95% CI: 2.99–5.15) in an exploratory expanded analysis including SCC and broader NMSC populations; this estimate should be interpreted as a summary of heterogeneous keratinocyte cancer populations rather than as representative of BCC alone. None of the included studies had an untreated comparator group, so the pre–post results describe the change in DLQI score following treatment rather than a treatment effect. The pooled reduction was 2.38 points (95% CI: 0.56–4.19) in the BCC-only and 1.90 points (95% CI: 0.84–2.96) in the expanded pre–post analysis. Both fall below the minimal clinically important difference for the DLQI of approximately four points. Heterogeneity was very high throughout (I2 > 95% for baseline analyses), so the pooled means summarize highly dispersed evidence and cannot be read as representative average values. Surgical treatment appeared to show a greater improvement in DLQI scores compared with the single available radiotherapy cohort. This comparison should be interpreted descriptively due to the inclusion of only one radiotherapy study. Conclusions: Patients with BCC and other NMSCs experience measurable impairment in dermatology-related quality of life before treatment, although the overall burden is generally mild. Treatment is associated with improvement in DLQI scores; however, the magnitude of change is modestand may not consistently exceed thresholds considered clinically meaningful. Evidence  \nregarding differenc","cbCairYMrHBSDCJe","https://ap.wps.com/l/cbCairYMrHBSDCJe","pdf",2152537,22,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What instrument was used to measure dermatology-related quality of life in this review?\",\"answer\":\"The study used the Dermatology Life Quality Index (DLQI) exclusively to assess dermatology-related quality of life.\"},{\"question\":\"How were included studies identified and selected?\",\"answer\":\"A systematic search of PubMed, Scopus, and Web of Science was conducted until 5 April 2026, following PRISMA guidelines, and studies reporting DLQI outcomes in adult BCC or NMSC populations were included.\"},{\"question\":\"Did treatment improve DLQI scores, and was the change clinically meaningful?\",\"answer\":\"Treatment was associated with reduced DLQI scores, but the pooled reduction generally fell below the minimal clinically important difference of about four points, indicating modest and not consistently clinically meaningful improvement.\"}]","Dermatology-Related Quality of Life Measured with the Dermatology Life Quality Index in Basal Cell Carcinoma and Other Non-Melanoma Skin Cancers - A Systematic Review and Exploratory Meta-Analysis | PDF",1790123507,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf227a512cc7b55ee8f8ec2863dc89a4.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6efddcb3a33b6fdc3045ad8c42ffb99.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9dfe33b720f2db69b48fe1ce3491bf3.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52ef01f1210879746e3df19dd86def84.webp",980,1385]